POSTTRANSLATIONAL AND ACTIVATION-DEPENDENT MODIFICATIONS OF THE G-PROTEIN-COUPLED THROMBIN RECEPTOR

被引:70
作者
VOURETCRAVIARI, V
GRALL, D
CHAMBARD, JC
RASMUSSEN, UB
POUYSSEGUR, J
VANOBBERGHENSCHILLING, E
机构
[1] CTR BIOCHIM,CNRS,UMR 134,F-06108 NICE 2,FRANCE
[2] TRANSGENE SA,F-67082 STRASBOURG,FRANCE
关键词
D O I
10.1074/jbc.270.14.8367
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of the present study was to analyze the post-translational and activation-dependent modifications of the G protein coupled thrombin receptor. A human receptor cDNA was engineered to encode an epitope tag derived from the vesicular stomatitis virus glycoprotein at the COOH terminus of the receptor and expressed in human embryonic kidney 293 cells. We show here that the mature receptor is a glycosylated protein with an apparent molecular mass ranging from 68 to 80 kDa by SDS-polyacrylamide gel electrophoresis. Removal of asparagine-linked oligosaccharides with N-glycosidase F leads to the appearance of a 36-40-kDa receptor species. The current model for receptor activation by thrombin involves specific hydrolysis of the arginine-4l/serine-42 (Arg-41/Ser-42) peptide bond. Cleavage of the receptor by thrombin was demonstrated directly by Western analyses performed on membranes and glycoprotein-enriched lysates from transfected cells. Whereas thrombin treatment of cells results in increased mobility of the receptor in SDS-polyacrylamide gel electrophoresis, we found that their treatment with the thrombin receptor agonist peptide leads to a decrease in thrombin receptor mobility due, in part, to phosphorylation. The serine proteases trypsin and plasmin also cleave and activate the receptor similar to thrombin, whereas chymotrypsin cleaves the receptor at a site distal to Arg-41, thus rendering it unresponsive to thrombin while still responsive to thrombin receptor agonist peptide.
引用
收藏
页码:8367 / 8372
页数:6
相关论文
共 28 条
[1]   THE THROMBIN RECEPTOR EXTRACELLULAR DOMAIN CONTAINS SITES CRUCIAL FOR PEPTIDE LIGAND INDUCED ACTIVATION [J].
BAHOU, WF ;
COLLER, BS ;
POTTER, CL ;
NORTON, KJ ;
KUTOK, JL ;
GOLIGORSKY, MS .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1405-1413
[2]  
BRASS LF, 1993, THROMB HAEMOSTASIS, V70, P217
[3]  
BRASS LF, 1992, J BIOL CHEM, V267, P13795
[4]  
CHEN J, 1994, J BIOL CHEM, V269, P16041
[5]   CLONED PLATELET THROMBIN RECEPTOR IS NECESSARY FOR THROMBIN-INDUCED PLATELET ACTIVATION [J].
HUNG, DT ;
VU, TKH ;
WHEATON, VI ;
ISHII, K ;
COUGHLIN, SR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) :1350-1353
[6]   MIRROR-IMAGE ANTAGONISTS OF THROMBIN-INDUCED PLATELET ACTIVATION BASED ON THROMBIN RECEPTOR STRUCTURE [J].
HUNG, DT ;
VU, TKH ;
WHEATON, VI ;
CHARO, IF ;
NELKEN, NA ;
ESMON, N ;
ESMON, CT ;
COUGHLIN, SR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) :444-450
[7]  
ISHII K, 1994, J BIOL CHEM, V269, P1125
[8]  
ISHII K, 1993, J BIOL CHEM, V268, P9780
[9]   STRUCTURE AND FUNCTION IN RHODOPSIN - THE ROLE OF ASPARAGINE-LINKED GLYCOSYLATION [J].
KAUSHAL, S ;
RIDGE, KD ;
KHORANA, HG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4024-4028